Log in
Enquire now
‌

US Patent 7504214 Predicting outcome with tamoxifen in breast cancer

Patent 7504214 was granted and assigned to Biotheranostics on March, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Biotheranostics
Biotheranostics
0
Date Filed
December 2, 2003
0
Date of Patent
March 17, 2009
0
Patent Application Number
10727100
0
Patent Citations Received
‌
US Patent 12125691 Systems and methods for sample analysis using swabs
0
‌
US Patent 11754499 Enzyme quantification
‌
US Patent 11768198 Compositions and methods for molecular labeling
‌
US Patent 11786872 Vitro evolution in microfluidic systems
‌
US Patent 11821109 Compartmentalised combinatorial chemistry by microfluidic control
0
‌
US Patent 11965877 Compositions and methods for molecular labeling
0
‌
US Patent 12091710 Systems and methods for handling microfluidic droplets
0
‌
US Patent 11710626 Systems and methods for sample analysis using swabs
0
‌
US Patent 11747327 Compositions and methods for molecular labeling
Patent Inventor Names
Mark G. Erlander
0
Xiao-Jun Ma
0
Dennis C. Sgroi
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7504214
0
Patent Primary Examiner
‌
Celine X Qian
0

Find more entities like US Patent 7504214 Predicting outcome with tamoxifen in breast cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.